focus -WSS

focus

author：comprehensive 2025-09-28 20:23:09 - browse：21213

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Ebola public health emergency is over, WHO declares

WSS

Why some people catch Covid but never get sick

Pushing for an NIH office for post

First U.S. drug developed to treat liver disease MASH is approved

Resistance to cancer drugs: A new genetic explanation

President Biden's budget: Here's what you might have missed

DOJ, FTC to increase scrutiny of all types of health care mergers

focus

focus

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Ebola public health emergency is over, WHO declares

United colonoscopy coverage change 'may cost lives,' doctors say

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Activists slam private health insurers over coverage restrictions

EPA limits use of carcinogenic gas for sterilizing medical devices

State Dept. review finds Biden bears some blame for Afghanistan failures

RaDonda Vaught links Vanderbilt hospital issues to patient death

Cancer drug shortages should be causing more outrage

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Male and female sex labels in research insufficient, scientists say

WuXi out of biotech trade group, U.S. and China relations to blame

President Biden's budget: Here's what you might have missed

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

leisure time

entertainment

hotspot

Wikipedia